인쇄하기
취소

Will Zemiglo case be accelerated with Sanofi’s submission of marketing data?

Published: 2018-01-30 16:00:34
Updated: 2018-01-30 16:00:34

The Zemiglo license case which has been postponed by the debate over submission of marketing data might get accelerated.

On the 26th, the Seoul Central District Court Civil Case Division 17 conducted the 8th defense for the damage suit filed by Sanofi Aventis against LG Chem(former LG Life Sciences) and Daewoong Pharmaceutical regarding Zemiglo license.

Taking only a short time, the 8th defen...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.